Yuri T et al. |
Perillyl alcohol inhibits human breast cancer cell growth in vitro and in vivo. |
2004 |
Breast Cancer Res. Treat. |
pmid:15026623
|
Jung HJ et al. |
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities. |
2012 |
Blood |
pmid:22294726
|
Kim D and Ortiz de Montellano PR |
Tricistronic overexpression of cytochrome P450cam, putidaredoxin, and putidaredoxin reductase provides a useful cell-based catalytic system. |
2009 |
Biotechnol. Lett. |
pmid:19458919
|
Cornelissen S et al. |
Whole-cell-based CYP153A6-catalyzed (S)-limonene hydroxylation efficiency depends on host background and profits from monoterpene uptake via AlkL. |
2013 |
Biotechnol. Bioeng. |
pmid:23239244
|
Yamamoto Y et al. |
Synthesis of phosphatidylated-monoterpene alcohols catalyzed by phospholipase D and their antiproliferative effects on human cancer cells. |
2008 |
Bioorg. Med. Chem. Lett. |
pmid:18556205
|
Sundin T et al. |
The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells. |
2012 |
Biochimie |
pmid:22902867
|
Ren Z et al. |
Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells. |
1997 |
Biochem. Pharmacol. |
pmid:9296357
|
Imamura M et al. |
Perillyl alcohol suppresses antigen-induced immune responses in the lung. |
2014 |
Biochem. Biophys. Res. Commun. |
pmid:24309112
|
da Fonseca CO et al. |
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. |
2008 Jul-Aug |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:18726148
|
D'Alincourt Salazar M et al. |
Intranasal administration of perillyl alcohol activates peripheral and bronchus-associated immune system in vivo. |
2014 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:24257817
|